Dashboard
Manage Tickers

XGN EXAGEN INC.

Nasdaq exagen.com


$ 11.53 $ -0.23 (-1.95 %)    

Friday, 17-Oct-2025 15:59:55 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 604.92 $ 3.94 (0.66 %)
DIA $ 461.73 $ 2.22 (0.48 %)
SPY $ 665.28 $ 3.75 (0.57 %)
TLT $ 91.09 $ -0.14 (-0.15 %)
GLD $ 391.28 $ -7.46 (-1.88 %)
$ 11.54
$ 11.75
$ 11.40 x 300
$ 11.99 x 14
$ 11.35 - $ 11.77
$ 2.38 - $ 11.99
181,282
na
253.92M
$ 0.79
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 07-29-2025 06-30-2025 10-Q
2 05-05-2025 03-31-2025 10-Q
3 03-11-2025 12-31-2024 10-K
4 11-12-2024 09-30-2024 10-Q
5 08-05-2024 06-30-2024 10-Q
6 05-13-2024 03-31-2024 10-Q
7 03-18-2024 12-31-2023 10-K
8 11-13-2023 09-30-2023 10-Q
9 08-07-2023 06-30-2023 10-Q
10 05-15-2023 03-31-2023 10-Q
11 03-20-2023 12-31-2022 10-K
12 11-21-2022 09-30-2022 10-Q
13 08-04-2022 06-30-2022 10-Q
14 05-11-2022 03-31-2022 10-Q
15 03-22-2022 12-31-2021 10-K
16 11-10-2021 09-30-2021 10-Q
17 08-09-2021 06-30-2021 10-Q
18 05-11-2021 03-31-2021 10-Q
19 03-16-2021 12-31-2020 10-K
20 11-10-2020 09-30-2020 10-Q
21 07-28-2020 06-30-2020 10-Q
22 05-11-2020 03-31-2020 10-Q
23 03-25-2020 12-31-2019 10-K
24 11-12-2019 09-30-2019 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

keybanc-maintains-overweight-on-exagen-raises-price-target-to-15
Keybanc Maintains Overweight on Exagen, Ra...
10/14/2025 13:46:07

Keybanc analyst Paul Knight maintains Exagen (NASDAQ:XGN) with a Overweight and raises the price target from $12 to $15.

beyond-the-numbers-4-analysts-discuss-exagen-stock
Beyond The Numbers: 4 Analysts Discuss Exa...
09/11/2025 12:02:30

b-riley-securities-initiates-coverage-on-exagen-with-buy-rating-announces-price-target-of-15
B. Riley Securities Initiates Coverage On ...
09/11/2025 11:32:51

B. Riley Securities analyst Anderson Schock initiates coverage on Exagen (NASDAQ:XGN) with a Buy rating and announces Price ...

canaccord-genuity-maintains-buy-on-exagen-raises-price-target-to-11
Canaccord Genuity Maintains Buy on Exagen,...
07/30/2025 12:22:22

Canaccord Genuity analyst Kyle Mikson maintains Exagen (NASDAQ:XGN) with a Buy and raises the price target from $8 to $11.

what-analysts-are-saying-about-exagen-stock
What Analysts Are Saying About Exagen Stock
07/30/2025 12:00:38

keybanc-upgrades-exagen-to-overweight-maintains-price-target-to-12
Keybanc Upgrades Exagen to Overweight, Mai...
07/30/2025 11:02:43

Keybanc analyst Paul Knight upgrades Exagen (NASDAQ:XGN) from Sector Weight to Overweight and maintains the price target fro...

Core News & Articles
12 Health Care Stocks Moving In Tuesday's ...
07/29/2025 17:06:19

exagen-sees-fy2025-sales-65000m-70000m-vs-65515m-est
Exagen Sees FY2025 Sales $65.000M-$70.000M...
07/29/2025 13:10:44

Exagen (NASDAQ:XGN) sees FY2025 sales of $65.000 million-$70.000 million vs $65.515 million analyst estimate.

exagen-q2-adj-eps-018-misses-014-estimate-sales-17202m-beat-16233m-estimate
Exagen Q2 Adj. EPS $(0.18) Misses $(0.14) ...
07/29/2025 12:06:20

Exagen (NASDAQ:XGN) reported quarterly losses of $(0.18) per share which missed the analyst consensus estimate of $(0.14) by 28...

Core News & Articles
Earnings Scheduled For July 29, 2025
07/29/2025 08:32:31

craig-hallum-initiates-coverage-on-exagen-with-buy-rating-announces-price-target-of-12
Craig-Hallum Initiates Coverage On Exagen ...
07/23/2025 18:14:01

Craig-Hallum analyst John Wilkin initiates coverage on Exagen (NASDAQ:XGN) with a Buy rating and announces Price Target of $12.

cantor-fitzgerald-maintains-overweight-on-exagen-lowers-price-target-to-7
Cantor Fitzgerald Maintains Overweight on ...
05/15/2025 15:36:22

Cantor Fitzgerald analyst Ross Osborn maintains Exagen (NASDAQ:XGN) with a Overweight and lowers the price target from $8 to...

canaccord-genuity-maintains-buy-on-exagen-raises-price-target-to-8
Canaccord Genuity Maintains Buy on Exagen,...
05/13/2025 14:05:18

Canaccord Genuity analyst Kyle Mikson maintains Exagen (NASDAQ:XGN) with a Buy and raises the price target from $7 to $8.

exagen-prices-3350000-share-public-offering-at-525-per-share
Exagen Prices 3,350,000 Share Public Offer...
05/08/2025 12:31:11

Core News & Articles
12 Health Care Stocks Moving In Thursday's...
05/08/2025 12:07:05

Core News & Articles
12 Health Care Stocks Moving In Wednesday'...
05/07/2025 21:05:48

exagen-announces-proposed-public-offering-size-not-disclosed
Exagen Announces Proposed Public Offering;...
05/07/2025 20:13:19

exagen-fy2025--revenue-expected-to-be-more-than-6500m-vs-6455m-est
Exagen FY2025 Revenue expected to be more...
05/05/2025 12:10:02

Exagen (NASDAQ:XGN) FY2025 Revenue expected to be more than $65.00M vs $64.55M Est

exagen-q1-gaap-eps-020-inline-sales-1550m-beat-1454m-estimate
Exagen Q1 GAAP EPS $(0.20), Inline, Sales ...
05/05/2025 12:02:12

Exagen (NASDAQ:XGN) reported quarterly losses of $(0.20) per share which met the analyst consensus estimate. This is a 5.26 per...

Core News & Articles
Earnings Scheduled For May 5, 2025
05/05/2025 08:32:22

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION